Zhitong Finance App News, Baicheng Pharmaceutical (301096.SZ) issued an announcement. The innovative drug BIOS0635-048 tablets independently developed by the company obtained the National Drug Administration (NMPA) clinical trial approval notice, agreeing to conduct clinical trials of this single drug in advanced solid tumors.
智通財經·07/27/2026 08:25:04
語音播報
Zhitong Finance App News, Baicheng Pharmaceutical (301096.SZ) issued an announcement. The innovative drug BIOS0635-048 tablets independently developed by the company obtained the National Drug Administration (NMPA) clinical trial approval notice, agreeing to conduct clinical trials of this single drug in advanced solid tumors.